S
Silvio Danese
Researcher at Humanitas University
Publications - 1184
Citations - 47449
Silvio Danese is an academic researcher from Humanitas University. The author has contributed to research in topics: Ulcerative colitis & Medicine. The author has an hindex of 90, co-authored 893 publications receiving 35801 citations. Previous affiliations of Silvio Danese include The Catholic University of America & Catholic University of the Sacred Heart.
Papers
More filters
Journal ArticleDOI
Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study.
TL;DR: The authors' analysis highlights factors able to explain a substantial portion of incidence variation across countries, and shows that expenditure for health and physical inactivity prevalence were consistent in low/middle- and high-income countries.
Journal ArticleDOI
Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
Marie Muller,Julien Broséus,Pierre Feugier,Catherine Thieblemont,Laurent Beaugerie,Silvio Danese,Djésia Arnone,Ndeye Coumba Ndiaye,Tunay Kökten,Rémi Houlgatte,Laurent Peyrin-Biroulet +10 more
TL;DR: It is highlighted that PIL (especially DLBCL subtype) is significantly more frequent in patients with IBD and represents the most common entity and MALT lymphoma is extremely rare in IBD population, however, the overall quality of the evidence is low.
Journal ArticleDOI
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
Mina Hassan-Zahraee,Zhan Ye,Li Xi,Mary Lynn Baniecki,Xingpeng Li,Craig L. Hyde,Jenny Zhang,Nancy Raha,Fridrik Karlsson,Jie Quan,Daniel Ziemek,Srividya Neelakantan,Christopher Lepsy,Jessica R. Allegretti,Jacek Romatowski,Ellen Scherl,Maria Kłopocka,Silvio Danese,Deepa E. Chandra,Uwe Schoenbeck,Michael S. Vincent,Randy S. Longman,Kenneth E. Hung +22 more
TL;DR: In this paper, the first-in-class treatment PF-06480605 targets the tumor necrosis factor-like ligand 1A (TL1A) molecule in humans.
Journal ArticleDOI
The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies.
TL;DR: This review aims to summarize the state-of-the-art in this field, ultimately providing insights for the development of innovative anti-CRC therapies that promote the endogenous lipid-mediated resolution of CRC-associated inflammation.